Document is current
Any future updates will be listed below
-
Authors
Yu-Wai-Man, Patrick https://orcid.org/0000-0001-7847-9320
Newman, Nancy J.
Carelli, Valerio
La Morgia, Chiara
Biousse, Valérie
Bandello, Francesco M.
Clermont, Catherine Vignal
Campillo, Lorena Castillo
Leruez, Stephanie
Moster, Mark L.
Cestari, Dean M.
Foroozan, Rod
Sadun, Alfredo
Karanjia, Rustum
Jurkute, Neringa https://orcid.org/0000-0002-3092-7451
Blouin, Laure
Taiel, Magali https://orcid.org/0000-0003-1139-5178
Sahel, José-Alain
,
Hussain, Rima
Jorany, Rasha
Sheel, Priyansha
DuBois, Lindreth
Carbonelli, Michele
Di Vito, Lidia
Romagnoli, Martina
DeBusk, Adam A.
Massini, Maria
Hage, Rabih
Heilweil, Gad
Tsui, Irena
Garcia, Virginia
Morilla, Antonio
Barboni, Piero
Cascavilla, Maria Lucia
Battista, Marco
Calcagno, Francesca
Pina, Adelaide
-
Funding
Funding for this research was provided by:
GenSight Biologics
- License Information
-
More Information
Article History
Received: 29 January 2021
Revised: 24 March 2021
Accepted: 1 April 2021
First Online: 28 April 2021
Compliance with ethical standards
:
: PYWM is a consultant for GenSight Biologics and Stealth BioTherapeutics and has received research support from GenSight Biologies and Santhera Pharmaceuticals. NJN is a consultant for GenSight Biologics, Santhera Pharmaceuticals and Stealth BioTherapeutics, has received research support from GenSight Biologics and Santhera Pharmaceuticals, served on the Data Safety Monitoring Board for the Quark NAION study and is a medical-legal consultant. VC is a consultant for Santhera Pharmaceuticals, GenSight Biologics, and Stealth BioTherapeutics and has received research support from Santhera Pharmaceuticals and Stealth BioTherapeutics. CV-C is a consultant for Santhera Pharmaceuticals and GenSight Biologics. VB is a consultant for GenSight Biologics. MM is a consultant for GenSight Biologics and has received research support from GenSight. AAS is a consultant for Stealth BioTherapeutics. LB and MT are GenSight Biologics employees. JAS is a co-founder and shareholder of GenSight Biologics, and a patent co-author on allotopic transport. Authors declare competing financial interests in relation with the work submitted (see “Acknowledgements” for details).
